Loading...
Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2"
Saved in:
| Published in: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267349/ https://ncbi.nlm.nih.gov/pubmed/32353191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1878 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|